On June 6, Liquidia Technologies rose 5.9% in after-hours trading, trading at $63.4 USD/share, with trading volume of $2.1479 million.
Within the Pharmacy sector where Liquidia belongs, the overall sector showed broad weakness. Among individual stocks, Eli Lilly down 0.97%, Johnson & Johnson down 0.31%, Merck down 0.55%, Pfizer down 0.22%, Bristol-Myers Squibb down 0.12%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)